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Roles of Predicted Glycosyltransferases in the Biosynthesis of the
Rhizobium etli CE3 O Antigen
Kristylea J. Ojeda,* Laurie Simonds, K. Dale Noel
Department of Biological Sciences, Marquette University, Milwaukee, Wisconsin, USA
TheRhizobium etliCE3O antigen is a fixed-length heteropolymer. The genetic regions required for its synthesis have been identified,
and the nucleotide sequences are known. The structure of theO antigen has been determined, but the roles of specific genes in synthe-
sizing this structure are relatively unclear.Within the knownO-antigen genetic clusters of this strain, nine open reading frames (ORFs)
were found to contain a conserved glycosyltransferase domain. EachORFwasmutated, and the resultingmutant lipopolysaccharide
(LPS)was analyzed. Tricine SDS-PAGE revealed stepwise truncations of theO antigen thatwere consistentwith differences inmutant
LPS sugar compositions and reactivitywithO-antigen-specificmonoclonal antibodies. Based on these results and current theories of
O-antigen synthesis, specific roles were deduced for each of the nine glycosyltransferases, and amodel for biosynthesis of theR. etli
CE3Oantigenwas proposed. In thismodel, O-antigen biosynthesis is initiatedwith the addition ofN-acetyl-quinovosamine-phos-
phate (QuiNAc-P) to bactoprenol-phosphate by glycosyltransferaseWreU.GlycosyltransferasesWreG,WreE,WreS, andWreTwould
each act once to attachmannose, fucose, a second fucose, and 3-O-methyl-6-deoxytalose (3OMe6dTal), respectively.WreHwould then
catalyze the addition ofmethyl glucuronate (MeGlcA) to complete the first instance of theO-antigen repeat unit. Four subsequent re-
peats of this unit composed of fucose, 3OMe6dTal, andMeGlcAwould be assembled by a cycle of reactions catalyzed by two additional
glycosyltransferases,WreMandWreL, alongwithWreH. Finally, theO antigenwould be capped by attachment of di- or tri-O-methyl-
ated fucose as catalyzed by glycosyltransferaseWreB.
Lipopolysaccharide (LPS) is the major surface component ofGram-negative bacteria and consists of lipid A, a core oligo-
saccharide, and an O-specific polysaccharide or O antigen (1).
While the composition, structure, and synthesis of lipid A and
core regions are often similar, especially between closely related
species, the O-antigen portions can vary considerably even be-
tween strains of the same species (1, 2). O antigens can consist of a
polymer of a single sugar (homopolymer) or many different sug-
ars (heteropolymer). In both types of polymers, the number of
repeating units can be either fixed or varied, giving rise to O anti-
gens of uniform and modal lengths, respectively (1, 2).
Further variation occurs due to the fact that a given O antigen
is synthesized by one of two main types of pathways, one depen-
dent onWzy polymerase and the other involving an ATP-binding
cassette (ABC) transporter (1). In each pathway, the initial reac-
tion attaches a sugar-phosphate to bactoprenol phosphate (BpP),
creating the first in a series of pyrophosphoryl-bactoprenol-linked
(BpPP) oligosaccharide intermediates (3–5). O-antigen biosyn-
thesis by the Wzy pathway assembles on the cytoplasmic face of
the inner membrane a single repeating unit on BpPP, which is
then “flipped” across the inner membrane by protein Wzx. In the
periplasm, a growing O-antigen chain on another BpPP is trans-
ferred, through the action of anO-antigen polymerase encoded by
wzy, to the nonreducing end of the newly “flipped” repeating unit.
Thus, elongation of the O antigen occurs by extension at the re-
ducing end in this type of O-antigen synthesis, like peptidoglycan
synthesis. In contrast, O-antigen biosynthesis by the ABC trans-
porter pathway assembles the complete O antigen on BpPP at the
cytoplasmic face of the inner membrane. The subsequent glyco-
syltransferase reactions elongate the O antigen by the addition of
sugars at the nonreducing end (6). An ABC transporter, typically
composed of subunitsWzm andWzt (7, 8), translocates the com-
pletedO-antigen-BpPP intermediate to the periplasmic face of the
innermembrane. Both pathways converge again at the pointwhen
the O antigen is ligated to the lipid A-core regions (9, 10), and the
mature LPS is transported to the outer membrane (11, 12).
The O-antigen portion of the Rhizobium etli CE3 LPS is a het-
eropolymer of uniform length,mostmolecules having five repeats of
a three-sugar unit (Fig. 1) (13). Having homologs ofwzm andwzt in
the chromosomal O-antigen genetic cluster (Fig. 2), R. etli CE3 is
postulated to synthesize its O antigen by the ABC transporter path-
way (2, 14, 15). For this type of synthesis, the terms primer, adaptor,
repeat-unit domain, and chain terminator have been proposed for
different portions of the O-chain (1, 4), as indicated in Fig. 1. Based
on considerations discussed below, it is likely that the primer sugar of
the CE3 O antigen is 2-N-acetamido-2,6-dideoxyglucose (N-acetyl-
quinovosamine [QuiNAc]). Attached to the primer are the four sug-
ars of the adaptor region, which are defined here as sugars added
through the actionof glycosyltransferases that act onceperOantigen.
In strain CE3, mannose and the first fucose (FucI) are obvious com-
ponents of the adaptor region, but perhaps less obvious are two sug-
ars in the first instance of the repeat unit. One of these latter two
sugars is a fucose (FucII), which is attached to FucI, whereas the re-
maining repeat-unit fucoses (FucIII-VI) are attached to methyl gluc-
uronate (MeGlcA). Therefore, the enzyme that catalyzes the addition
of FucII should act only once. The last sugar of the adaptor, either a
Received 12 November 2012 Accepted 15 February 2013
Published ahead of print 22 February 2013
Address correspondence to K. Dale Noel, Dale.Noel@Marquette.edu.
* Present address: Kristylea J. Ojeda, Department of Natural Sciences, Dominican
University of California, San Rafael, California, USA.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/JB.02080-12.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JB.02080-12
May 2013 Volume 195 Number 9 Journal of Bacteriology p. 1949–1958 jb.asm.org 1949
 o
n
 January 23, 2014 by M
arquette University Libraries
http://jb.asm.org/
D
ow
nloaded from
 
MeGlcA or 3-O-methyl-6-deoxytalose (3OMe6dTal), is also added
to an L-fucose, but only to FucII and not to FucI (13). One way to
prevent its addition to FucI uses the fact that the responsible enzyme
acts on the acceptor substrate only if it ends in two linked fucoses
(FucII-FucI-), which is true only at this point in the synthesis. An
enzymewith such a specificity should act only once in the formation
of an O-antigen chain. After completion of the four-sugar adaptor,
synthesis would then shift to three additional enzymes, which would
recognize portions of the acceptor substrate that repeatedly appear in
a cycle of three reactions resulting in the assembly of the complete
repeat-unit domain. A final enzyme would catalyze the addition of
the terminal residue, 2,3-di-O-methylfucose, which is variably
O-methylated at position 4. This model of CE3 O-antigen synthesis
predicts nine different glycosyltransferases.
Nearly all the genes required to synthesize the known R. etli
CE3 O-antigen structure are located in three separate loci in the
genome (2, 14, 16). Except for well-known orthologous genes,
such as fcl and gmd, genes devoted to R. etli CE3 O-antigen syn-
thesis have been given the designationwre (Fig. 2) (17) in order to
conformwith the conventions of namingO-antigen-related genes
(18). (For example, genes in Fig. 2 designated fcl, gmd,wreE,wreU,
and wreV in various previous contexts have been referred to as
nolK, noeL, exoU, lps1, and lps2, respectively [14, 19].) Besides
genes for the ABCO-antigen transporter (15), thewre loci include
genes predicted to encode proteins for the synthesis of nucleotides
of O-antigen-specific sugars (2, 19–21). Also within two of these
loci are wre genes predicted to encode the glycosyltransferases
needed to connect together the sugars from these sugar nucleo-
tides. The chromosomal genetic cluster contains eight open read-
ing frames (ORFs) whose sequences are predicted to encode gly-
cosyltransferases, and one such ORF is located on plasmid
pCFN42b (Fig. 2). One of theseORFs (wreB) has been shown to be
required for the addition of the terminal residue of the O antigen
(17). In this study, the LPSs frommutants defective in each of the
other predicted glycosyltransferase ORFs were analyzed. Each
ORF was shown to be required for O-antigen synthesis. From the
FIG 1 R. etli CE3 LPS I structure (13, 45). The O antigen is hypothesized to begin with N-acetyl-quinovosamine (QuiNAc) at the reducing end (see the text)
followed by mannose (Man) and fucose (Fuc) residues. After that are five repeats (in most molecules) of a unit consisting of Fuc, 3-O-methyl-6-deoxytalose
residue (3OMe6dTal), and methyl glucuronate (MeGlcA). One repeating unit is shown separately in order to emphasize that two of its residues are added by
glycosyltransferases that likely act only once and therefore belong to the biosynthetic adaptor region (see the text). NonstoichiometricO-methylation occurs at
position 2 of the fucose (2OMeFuc) of the repeating units (not shown) (13, 35). The O-antigen backbone is capped with a 2,3-di-O-methylfucose terminal
residue that is variably O-methylated at position 4, as indicated by parentheses. O-antigen-specific sugars are shown in boldface type, and residues within the
primer, adaptor region, repeat-unit domain, and chain terminator are indicated. The structure of the core region, consisting of sugars 3-deoxy-D-manno-2-
octulonic acid (Kdo), galacturonic acid (GalA), mannose (Man), and galactose (Gal), is also shown.
FIG2 R. etliCE3O-antigen genetic clusters encoding putative glycosyltransferases. (A) TheR. etliCE3 chromosomalO-antigen genetic cluster spans nucleotides
784,527 to 812,262 of the genome sequence (14) and consists of 25 putative ORFs. (B) TheO-antigen genetic cluster on plasmid pCFN42b spans nucleotides 277
to 4,328 (14) and consists of 3 putative ORFs. The predicted glycosyltransferases are enlarged, and other related ORFs are indicated. ORFs RHE_PB00001,
RHE_CH00748, RHE_CH00749, RHE_CH00755, RHE_CH00756, RHE_CH00757, RHE_CH00761, RHE_CH00764, and RHE_CH00766 were named wreU,
wreG, wreH, wreM, wreL, wreT, wreS, wreE, and wreB, respectively. The relative locations of mutations are indicated by white triangles for mutations created by
insertion of antibiotic cassettes and black triangles for mutations created by Tn5mutagenesis. The strain numbers carrying these mutations are indicated above
or below the triangles.
Ojeda et al.
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LPS phenotypes, the encoded glycosyltransferases were assigned
particular roles in synthesis of the primer, adaptor, or repeat-unit
domains.
MATERIALS AND METHODS
Bacterial strains andgrowth conditions.AllRhizobiumetli strains (Table
1) were derived from strain CE3, which is itself a streptomycin-resistant
derivative (22) of wild-type strain CFN42, whose genome nucleotide se-
quence has been determined (14). R. etli strains were grown to stationary
phase at 30°C on a rotating shaker in TY liquid medium (0.5% tryptone
[Difco Laboratories], 0.3% yeast extract [Difco], and 10 mM CaCl2).
Escherichia coli strains were grown in Luria-Bertani (LB) liquid medium
(1.0% tryptone, 0.5% yeast extract, and 0.5%NaCl) to stationary phase at
37°C on a rotating shaker. Agar medium contained 1.5% Bacto agar
(Difco).
Computer analysis of predicted protein sequences. Amino acid se-
quences of open reading frames (ORFs) deduced from R. etli CE3
genomic DNA sequence (14) were compared to nonredundant (nr) pro-
tein sequences by the BLAST search tool at the National Center for Bio-
technology Information (NCBI) (30) and the Carbohydrate Active En-
zyme (CAZy) database (http://www.cazy.org/). Alignment of amino acid
sequences was performed using ClustalW2, version 2.0.10.
Materials and techniques forDNA isolation.GenomicDNAwas iso-
lated from R. etli strains using the AquaPure genomic DNA isolation kit
(Bio-Rad) for use in cloning. E. coli JM109 (Promega) or INVF= (Invit-
rogen) competent cells were transformed (31), and plasmidswere isolated
from E. coli using QIAprep spin miniprep (Qiagen). DNA was recovered
from agarose gels using Geneclean II kit (MP Biomedicals, LLC.) and
modified with restriction enzymes purchased fromNew England BioLabs
(NEB) (Beverly, MA). Custom primers were synthesized by Eurofins
MWG Operon (Huntsville, AL).
Cloning and site-directed mutagenesis. Using PCR, fcl, lpcA, wreH,
wreL, wreS, wreT, and wreU were amplified separately from R. etli CE3
genomic DNA (for primer sequences, see Fig. S1 in the supplemental
material). PCR products were inserted into plasmid pEX18Tc (26). Either
the gentamicin resistance cassette (Gm) fromplasmid pUCGm(27) or the
TABLE 1 Bacterial strains and plasmids used in this study
Bacterial strain or plasmid Description and/or genotype or phenotypea Reference or source
Bacterial strains
R. etli strains
CE3 Wild-type strain; str-1 22
CE113 CE3 derivative; str-1 wreU 22
CE347 CE3 derivative; str-1 gmd::Tn5 23
CE358 CE3 derivative; str-1 wreG::Tn5 23
CE470 CE3 derivative; str-1 wreE::Km 24
CE503 CE3 derivative; str-1 wreB::Gm 17
CE518 CE3 derivative; str-1 wreL::Km This work
CE522 CE3 derivative; str-1 wreT::Km This work
CE532 CE3 derivative; str-1 lpcA::Km This work
CE542 CE3 derivative; str-1 wreM::Km 17
CE544 CE3 derivative; str-1 wreM::Gm 17
CE547 CE3 derivative; str-1 fcl::Km This work
CE549 CE3 derivative; str-1 fcl::Gm This work
CE551 CE3 derivative; str-1 wreS::Gm This work
CE552 CE3 derivative; str-1 wreS::Km This work
CE566 CE3 derivative; str-1 wreU::Km This work
CE570 CE3 derivative; str-1 wreH::Km This work
E. coli strains
INVF= F= endA1 recA1 hsdR17(rKmK) supE44 thi-1 gyrA96 relA1 80lacZM15 (lacZYA-argF)U169  Invitrogen
JM109 endA1 recA1 gyrA96 thi hsdR17(rK
mK
) relA1 supE44 (lac-proAB) [F= traD36 proAB lacIqZM15] Promega
MT616 pro thi endA hsdR supE44 recA-J6 pRK2013Km::Tn9 25
Plasmids
pEX18Tc Suicide plasmid; Tcr oriT sacB 26
pUCGm aaC1 gene cassette; Gmr 27
pBSL15 nptII gene cassette; Kmr 28
pBSL86 nptII gene cassette; Kmr 28
pKT72 fcl with Gm cassette inserted at SmaI site in pEX18Tc This work
pKT73 fcl with Km cassette inserted at SmaI site in pEX18Tc This work
pKT59 lpcA with Km cassette inserted at SalI site in pEX18Tc This work
pLS15 wreH with Km cassette inserted at BamHI site in pEX18Tc This work
pJB45 wreL with Gm cassette inserted at SmaI site in pEX18Tc This work
pKT81 wreS with Km cassette inserted in EcoRV deletion in pEX18Tc This work
pKT82 wreS with Gm cassette inserted in EcoRV deletion in pEX18Tc This work
pJB47 wreT with Gm cassette inserted at XhoI site in pEX18Tc This work
pKT98 wreU with Km cassette inserted in SalI deletion in pEX18Tc This work
pFAJ1708 Expression vector; Tcr 29
a The str-1 gene confers resistance to streptomycin. Km, insertion of kanamycin resistance cassette from pBSL86 or pBSL15; Gm, insertion of gentamicin resistance cassette from
pUCGm.
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kanamycin resistance cassette (Km) from plasmid pBSL15 (28) or plas-
mid pBSL86 (28) was inserted (Table 1).
Separately, plasmids carrying the mutated ORFs were transferred into
R. etli CE3 by triparental mating (32) with plasmid-mobilizer strain
MT616 (25) on TY agar plates. CE3 transconjugants containing these
constructs were selected and purified as previously described (17, 26).
Double-crossover recombinants were screened on TY agar plates supple-
mented with 1 g of tetracycline/ml. Of the recombinants that were sen-
sitive to 1 g of tetracycline/ml and resistant to 8% sucrose on TY agar,
colonies were saved after verifying by PCR the absence of the wild-type
allele and the presence of a mutant allele. The resulting R. etli strains were
CE549 and CE547 (fcl), CE532 (lpcA), CE570 (wreH), CE518 (wreL),
CE551 and CE552 (wreS), CE522 (wreT), and CE566 (wreU) (Table 1).
Complementation of wre mutants with wild-type DNA. Wild-type
wre gene sequences were cloned separately into plasmid pFAJ1708 (29). A
recombinant plasmid carrying a particular wild-type gene was transferred
by triparental mating, as described above, into a strain mutated in that
particular gene. Transconjugants were selected on TY agar plates supple-
mented with 30 g of nalidixic acid/ml, 200 g of streptomycin/ml, 5 g
of tetracycline/ml, and 30g of kanamycin/ml or 30g of gentamicin/ml.
The presence of the respective wild-type gene restored wild-type LPS I, as
determined by SDS-PAGE (see Fig. S3 in the supplemental material).
SDS-PAGE analysis. Bacterial cells from 0.5-ml portions of fully
grown cultures were pelleted and extracted in 0.1 ml of 1	 SDS-PAGE
sample buffer (16) and treated with proteinase K (0.25mg/ml) at 37°C for
1 h. After centrifugation to remove insoluble material, the SDS extracts
were subjected to electrophoresis by discontinuous Laemmli SDS-PAGE
(33)with 18% (wt/vol) acrylamide resolvingminigels or by discontinuous
Tricine SDS-PAGE as described previously (34). LPS in the gels was
stained by a previously described periodate-silver method (35).
Immunoblot analysis with MAb. After SDS-PAGE, some minigels
were electrotransferred to nitrocellulose before periodate-silver staining
of the residual gel contents. The dried nitrocellulose blots were immuno-
stained using monoclonal antibodies (MAb) JIM28 and JIM26 (generous
gifts from N. J. Brewin, Norwich, United Kingdom) (17, 36) and anti-rat
immunoglobulin M conjugated with alkaline phosphatase as previously
described (23, 36).
Purification of LPS. LPS was extracted fromwashed bacterial cell pel-
lets (from 6.0 liters of culture) by the hot phenol-water method (PWE)
(37). LPS was then subjected to dialysis and treated with 0.05 mg/ml
RNase A, 15 units/ml DNase I, and 0.05mg/ml proteinase K. After lyoph-
ilization, the LPS from the PWE aqueous phase was purified by gel filtra-
tion chromatography using a Sepharose 4B columnwith TEA-EDTA buf-
fer (0.03M triethylamine [TEA], 0.01M EDTA [pH 7.0]), a Sepharose 4B
column with ammonium formate buffer (5.0 mM ammonium formate
[pH 5.0]), a SephadexG-150 columnwith deoxycholic acid (DOC) buffer
(0.2 M NaCl, 1.0 mM EDTA, 10 mM Tris, 0.25% DOC) (16, 38), or a
Bio-Rad P-100 column with DOC buffer. The LPS content in fractions
eluted from the columns was assessed by SDS-PAGE of selected fractions.
The LPS-containing fractions were pooled, dialyzed against water, and
lyophilized. In the case of DOC buffer, the pooled fractions were dialyzed
first against DOC removal buffer (0.004MTris, 0.25%NaCl, 10% ethanol
[pH 9.3]) and second against water. The LPS from strains CE503 (17) and
CE566 was not subjected to purification by gel filtration, rather the PWE
aqueous phase was used for sugar composition analysis directly.
LPS compositions. For determination of neutral and amino sugars,
LPS preparations were treated with 2 M trifluoroacetic acid for 2 h at
121°C. After reduction with NaBD4 and acetylation, alditol acetate deriv-
atives of the LPS sugars were analyzed by gas chromatography (GC) on a
fused silica capillary SP2300 column (60m long; 0.53-mm inner diameter;
0.20-mfilm thickness) (Supelco) (13). The oven temperature was raised
1°C min1 from 150 to 185°C, 10°C min1 from 185 to 245°C, and then
maintained at 245°C for 35 min (35). For determination of glucuronic
acid and other acidic sugars, purified LPS was subjected to mild acid
hydrolysis to effect cleavage at 3-deoxy-D-manno-2-octulonic acid (Kdo)
residues. Up to 4 mg of purified LPS was dissolved in 1.0 ml of glass-
distilled water and incubated at 100°C for 10 min. Glacial acetic acid was
added to a concentration of 1%, and heating at 100°C was continued for
an additional 6 h. Lipid A was removed by extracting three times with 500
l of chloroform. The resulting aqueous phase, containing the O-antigen
and core regions, was dried. After methanolysis in methanolic 1 M HCl,
reaction with trimethylsilane, and extraction into hexane, the resulting
trimethylsilyl-methylglycosides were analyzed by gas chromatography on
an SPB-1 column (Supelco) (13). The oven temperature was raised 2°C
min1 from 150 to 180°C, 1°Cmin1 from 180 to 200°C, 5°Cmin1 from
200 to 300°C, and then maintained at 300°C for 25 min. Identification of
GC peaks as particular sugars was confirmed by gas chromatography cou-
pled to mass spectrometry (GC-MS) (data not shown).
Permeabilized cells and GDP-[3H]fucose labeling.Cells were grown
in TYmedium to stationary phase, inoculated 1:20 into 50 ml of fresh TY
medium, and grown at 30°C for about 24 h. Cell growth was measured
(optical density at 595 nm[OD595] of
0.5 to 0.6), and cells were collected
at 4,300	 g for 20 min. The cell pellet was washed once with 50 ml of 70
mMTris (pH 8.2) and resuspended in a volume of 70mMTris containing
10mMEDTA (pH 8.2) that gives a final cell concentration corresponding
to 100 times that of a suspension giving an OD595 of 1.0 (typically 250 to
280l) (39, 40). The cell suspensionwas transferred to a 1.5-ml centrifuge
tube, and cells were frozen in a dry ice-ethanol bath and thawed in a 37°C
water bath a total of three times. The permeabilized cells were stored at
80°C until use.
The standard reaction mixture (100 l) contained 70 l of permeab-
ilized cells, 10Ci ofGDP-[3H]fucose (PerkinElmer; 0.1mCi/ml, 15 to 35
Ci/mmol), 500 MUDP-N-acetylglucosamine, 500 MGDP-mannose,
and 100 MNADPH (39, 40). Reaction mixtures were incubated at 12°C
for 30 min and stopped by the addition of 0.5 ml of ice-cold 70 mM Tris
containing 10 mM EDTA (pH 8.2). After centrifugation, cell pellets were
washed twice with 0.3ml of 70mMTris (pH 8.2) and extracted twice with
100 l of chloroform-methanol-water (1:2:0.3). The combined extracts
were dried in a vacuum centrifuge and resuspended in 10 l of the chlo-
roform-methanol-water mixture. The entire volume was spotted on an
aluminum-backed precoated Silica-60 thin-layer chromatography (TLC)
plate and eluted in isobutyric acid–1.0 M ammonium hydroxide (5:3) for
8 h (41). The TLC plates were exposed to film at80°C.
RESULTS
The predicted glycosyltransferase ORFs and mutant construc-
tions.The protein sequences encoded byORFswreG,wreH,wreL,
wreT, wreS, wreE, wreB, and the  domain (17) of wreM (wreM)
within the O-antigen chromosomal genetic cluster and the wreU
ORF on endogenous plasmid pCFN42b of R. etli CE3 were each
predicted to contain a glycosyltransferase domain (see Fig. S2 in
the supplemental material). WreU best matched enzymes that
specifically transfer sugar phosphates, while the other eight pro-
teins were similar to families of enzymes that transfer sugars from
sugar-nucleotide substrates.
Strains were constructed with mutations in each of the nine
predicted glycosyltransferase ORFs (Table 1 and Fig. 2; see Fig. S1
in the supplemental material). The approach was to insert antibi-
otic resistance cassettes that in past work have been shown to not
cause polar effects on genes downstream in an operon (17). Lack
of polarity was confirmed by complementation of the mutants to
the wild-type LPS phenotype when a plasmid carrying only the
wild-type allele corresponding to the mutated allele was trans-
ferred into a given mutant (Fig. S3). LPSs from these mutant
strains were analyzed by SDS-PAGE, immunoblotting, and exam-
ining the sugar composition.
SDS-PAGE. SDS-PAGE resolves the LPS ofR. etliCE3 into two
distinct mobility classes (37), LPS I (containing the O antigen as
Ojeda et al.
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well as the lipid A and core regions) and LPS II (containing only
lipid A and core regions). All of the glycosyltransferase mutants
lacked the wild-type LPS I band, and several mutants synthesized
truncated LPS, which was usually less abundant than LPS I of the
wild type as indicated by silver staining (Fig. 3). wreU and wreG
mutants produced only LPS II and no visible, slower-moving
bands. On the other hand, wreE, wreS, wreT, and wreH mutants
gave rise to progressively longer versions of the O antigen, as in-
ferred from the presence of progressively slower-migrating bands,
and wreM and wreL mutants produced the slowest-moving
truncated LPSs. LPS I of the wreB mutant was produced in the
same abundance as the wild-type LPS I but exhibited a slightly
higher mobility (17).
The truncated LPS of the wreE mutant was compared to LPS
produced by mutants defective in the fcl and gmd genes. Because
Fcl and Gmd are required to convert GDP-mannose to GDP-
fucose (2, 42), mutants lacking either enzyme are expected to stop
O-antigen synthesis at the point fucose would be added. The trun-
cated LPS of the wreEmutant was visible just above LPS II (Fig. 3,
small black arrowhead), and this same LPS profile was seen in fcl
and gmdmutants (Fig. 3, lane 11; also data not shown).
Antigenicity. Additional information about the mutant LPSs
was gained by probing immunoblots with monoclonal antibodies
(MAb) JIM26 and JIM28 (17, 36). Although truncated LPS was
resolved best by Tricine SDS-PAGE (Fig. 3), immunoblot staining
was much more sensitive after Laemmli-type SDS-PAGE (Fig. 4).
MAb JIM26 recognizes the R. etli CE3 O antigen (36) and bound
the truncated LPSs from wreB, wreM, wreL, wreT, wreH, and
wreS mutants (Fig. 4B and data not shown). MAb JIM28 specifi-
cally requires the R. etli CE3 O-antigen terminal residue as part of
its epitope (17, 43). Only the truncated LPS of the wreMmutant
was bound by MAb JIM28, suggesting that the terminal residue
was present in the truncated O antigen of this strain (Fig. 4C).
Sugar compositions. The presence or absence of specific O-
antigen sugars was investigated by sugar composition analysis of
purified mutant LPSs (Table 2). As indicated on SDS-polyacryl-
amide gels (Fig. 3 and 4), the amount of the O-antigen sugars
contributed by the truncated LPSs would be low compared to the
amount of sugars of the wild-type LPS I and LPS II. To ensure that
background noise or contamination was not mistaken as a low
level of a given sugar in amutant, an lpcAmutant was constructed
(Table 1) and included as a negative control. In lpcAmutants, the
galactose of the core region is not attached (44); thus, the O anti-
gen cannot be attached to the truncated core, and the LPS of this
mutant should lack the O-antigen sugars entirely (Table 2).
The wreB mutant contained all the O-antigen sugars in wild-
FIG 3 Tricine SDS-PAGE of LPSs frommutants with lesions in the genes encoding the nine predicted glycosyltransferases. The O antigen on average consists of
five repeat-unit domains, thereby conferring themajor LPS I band in thewild type (WT) (lane 1). The less-abundant bands above and below thismajor bandmay
be due toO antigens having six and four repeat units, respectively. None of the glycosyltransferasemutants produced LPS I, and some synthesized truncated LPSs
of various sizes and abundances. The truncated LPSs ofwreE and fclmutants are visible above LPS II (small black arrowheads), whilewreG andwreUmutants did
not produce a visible truncated LPS. The positions of LPS bands are indicated to the right of the gel as follows: I, LPS I; II, LPS II; T, truncated LPS. Lane 1, WT
(CE3); lane 2,wreLmutant (CE518); lane 3,wreMmutant (CE542); lane 4,wreHmutant (CE570); lane 5,wreTmutant (CE522); lane 6,wreSmutant (CE551);
lane 7, wreEmutant (CE470); lane 8, wreGmutant (CE358); lane 9, wreUmutant (CE566); lane 10, wreEmutant (CE470); lane 11, fclmutant (CE549); lane 12,
WT (CE3); lane 13, wreBmutant (CE503). Lanes 1 to 9, lanes 10 and 11, and lanes 12 and 13 are from gels run separately.
FIG 4 MAb binding to truncated LPSs from mutants with lesions in genes
encoding the nine predicted glycosyltransferases. (A) 18%Laemmli SDS-poly-
acrylamide gel with LPS stained by silver-periodate. (B and C) LPS material
from the gel shown in panel A was transferred to nitrocellulose and probed
with MAb JIM26 (B) or MAb JIM28 (C). Lane 1, wreUmutant (CE113); lane
2, wreG mutant (CE358); lane 3, wreE mutant (CE470); lane 4, wreS mutant
(CE551); lane 5, wreLmutant (CE518); lane 6, wreTmutant (CE522); lane 7,
wreMmutant (CE542); lane 8,wreBmutant (CE503); lane 9,WT (CE3). The
positions of LPS bands are indicated to the right of the gel as follows: I, LPS I;
T, truncated LPS; II, LPS II.
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type amounts except the terminal residue, as previously reported
(17). Conversely, wreU mutants had undetectable levels of any
O-antigen-specific sugar, including quinovosamine (QuiN) (Ta-
ble 2). The other seven predicted glycosyltransferase mutants had
low but detectable levels of QuiN, which correlated with the low
abundance of their truncated LPS on gels.Mannosewas present in
all mutant LPSs, because it is a component of the core region (45);
thus, a minor amount of mannose contributed by a truncated O
antigen could not be distinguished frommannose contributed by
the core region. Of those mutant LPSs that contained QuiN, fu-
cose was detected in the truncated LPSs from wreS, wreT, wreH,
wreM, and wreL mutants, whereas it was not detected in wreG
and wreE mutants. Furthermore, consistent with the O-antigen
structure (Fig. 1), mutant LPSs that lacked QuiN (lpcA and wreU
mutants) also lacked detectable levels of fucose. For LPSs that
contained fucose, there was the potential to contain the rest of the
O-antigen sugars. LPSs from thewreH,wreM, andwreLmutants
contained 3OMe6dTal, whereas this sugar was not detected in the
LPSs from thewreS andwreTmutants. OnlywreMmutants con-
tained detectable levels of the terminal residue (Table 2), in accord
with the binding of its truncated LPS to MAb JIM28 (Fig. 4C).
There appeared to be a low, background level of glucuronic
acid (GlcA) in all LPS preparations, even from the negative-con-
trol lpcA mutant. This GlcA contamination was not due to re-
agents, and it was not found in rinses of the column matrices.
Mutant strains not expected to have GlcA—wreE, wreS, and lpcA
mutants-–had a fairly uniform amount of GlcA relative to the
core sugars. GlcA in the wreH mutant was at or very close to this
background level, but three mutants appeared to have relative
amounts indicating true GlcA contents in their truncated LPSs,
with the relative values in wreL and wreMmutant LPS prepara-
tions being significantly higher than in thewreTmutant LPS prep-
arations (Table 2).
Incorporation of [3H]fucose into the truncated LPSs from
wreE and wreSmutants.Of the sugars that may be unique to the
R. etli CE3 O antigen (Fig. 1), only fucose is available commer-
cially as the radioisotope-labeled portion of a nucleotide sugar
(GDP-fucose in this case). This allows an alternative approach to
demonstrate whether LPS from the wreSmutant differs from LPS
from the wreE mutant by having a fucose residue. Cells of each
strain were permeabilized and incubated with GDP-[3H]fucose.
Separation of the resulting fucose-labeled molecules by TLC re-
vealed a band unique to the wreSmutant (Fig. 5), consistent with
the presence of fucose in the truncated LPS of thewreSmutant and
the absence of fucose in the truncated LPS of the wreEmutant.
DISCUSSION
In this study, nine ORFs predicted to encode glycosyltransferases
were analyzed and determined to be necessary for the synthesis of
the Rhizobium etli CE3 O antigen. None of these predicted en-
zymes have been tested by an activity assay; however, amino acid
similarities with these particular glycosyltransferase families have
tended to be valid predictions of function (46, 47). Together, the
mutagenesis experiments suggest that O-antigen biosynthesis ini-
tiates with the activity of WreU and requires the sequential glyco-
syltransferase activities of WreG, WreE, WreS, WreT, WreH,
WreM, WreL, and WreB (Fig. 6). The arguments for these pro-
posed assignments are presented below.
FIG 5 In vitro labeling of permeabilized cells with GDP-[3H]fucose. Perme-
abilized cells were incubated with GDP-[3H]fucose, and the resulting labeled
molecules were extracted with chloroform-methanol-water (1:2:0.3), sepa-
rated by TLC in the isobutyric acid–1.0M ammonium hydroxide (5:3) solvent
(39–41), and visualized by fluorography. Ametabolite labeledwith radioactive
fucose that is present in the wreS mutant and absent in the wreE mutant is
shown by a box around the relevant part of the gel. The positions of unincor-
porated GDP-fucose (black arrow) and fucose (small black arrowhead) are
also indicated. Lane 1, wreSmutant (CE551); lane 2, wreEmutant (CE470).
TABLE 2 O-antigen sugar contents relative to two core sugars in the
mutantsa
Strain or
mutantb
Relative content of sugarc
QuiN Fuc 3OMe6dTal GlcA MexFuc Man Gal
WT 0.47 2.67 2.62 2.85 0.63 1.53 1.00
wreU NDd ND ND NTe ND 1.04 1.00
wreG 0.031 ND ND NT ND 0.95 1.00
fcl 0.014 ND ND NT ND 1.01 1.00
wreE 0.013 ND ND 0.021 ND 0.94 1.00
wreS 0.010 0.021 ND 0.018 ND 0.92 1.00
wreT 0.030 0.142 ND 0.056 ND 1.01 1.00
wreH 0.025 0.115 0.020 0.029 ND 0.91 1.00
wreL 0.018 0.091 0.011 0.092 ND 1.33 1.00
wreM 0.027 0.086 0.032 0.083 0.05 1.21 1.00
wreB 0.41 2.77 2.08 2.72 ND 1.47 1.00
lpcA ND 0.002 ND 0.018 ND 1.00 0.03
a The GC peak areas were used directly to calculate the relative content of each sugar
normalized to the GC peak area of Gal. The values for the negative-control lpcAmutant
were normalized to mannose, because the lpcAmutation blocks LPS core synthesis
before the addition of galactose. The internal standard sugar, Gal or Man, was set to a
value of 1.00 to reflect its molar amount in the LPS core. Neutral and amino sugar
compositions were determined as alditol acetates after acid hydrolysis of purified LPSs.
GlcA contents were determined from separate analysis after mild acid hydrolysis,
removal of lipid A, and conversion of sugars to trimethylsilyl-methylglycoside
derivatives.
b The strains were as follows: WT, CE3; wreU, CE113; wreG, CE358; wreE, CE470; fcl,
CE549; wreS, CE551; wreT, CE522; wreL, CE518; wreM, CE542; wreB, CE503; and
lpcA, CE532. Analysis of LPS from the wreUmutant strain CE566 exhibits the same
absence of O-antigen sugars as in strain CE113 (data not shown).
c Abbreviations for O-antigen-specific sugars: QuiN, quinovosamine; Fuc, fucose;
3OMe6dTal, 3-O-methyl-6-deoxytalose; GlcA, glucuronic acid; MexFuc, di-O-
methylfucose and tri-O-methylfucose. Abbreviations for core sugars: Man, mannose;
Gal, galactose. Man is present in both the O antigen and the core, but its presence in the
mutant LPSs is overwhelmingly due to LPS II.
d ND, not detected (i.e.,0.001 relative content of the sugar, normalized to galactose).
e NT, not tested.
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QuiNAc as the primer andWreU as the catalyst for its addi-
tion to BpP. Most of the mutants constructed in this study pro-
duced LPS with severely truncated O antigens, and the amount of
the truncated LPS was severely decreased in thesemutants relative
to wild-type O-antigen-containing LPS I (Fig. 3). Thus, in the
total LPS from any of these mutants, any O-antigen-specific sugar
was present in a small amount relative to that of the core-specific
sugars. As sugar analysis showed, QuiN was one of the sugars
present in much smaller amounts than the known core sugars
(Table 2). Previous chemical/genetic studies (48) indicated that
QuiNAc was linked to a Kdo residue (Fig. 1), and biosynthetic/
genetic studies (44, 45, 49, 50) provide strong evidence that this
Kdo is part of the biosynthetic core of the LPS. It follows from our
composition data and these previous conclusions that QuiNAc
not only is part of the O antigen but is the first sugar added in
O-antigen synthesis.
Based on sequence and mutation analyses in this study, the
wreU gene likely encodes the glycosyltransferase that initiates
O-antigen synthesis. The predicted protein sequence of WreU
(188 amino acids [aa]) is annotated as a prenyl-phosphate-
sugar-phosphotransferase (see Fig. S2 in the supplemental ma-
terial), the type of reaction generally required for the initial
reaction of O-antigen synthesis (1). In Salmonella enterica,
WbaP (476 aa) is the initiator of O-antigen synthesis, where the
C-terminal half of the protein functions as the undecaprenyl-
phosphate-galactosephosphotransferase (5, 51). Alignment of
the C-terminal portion of WbaP (aa 290 to 476) and WreU (aa
16 to 188) revealed a high degree of similarity between the
protein sequences, including the relative location of a pre-
dicted transmembrane domain and putative binding sites for
sugar nucleotides and prenyl-phosphate substrates (5) (data
not shown). Like WbaP-deficient strains, mutants defective in
wreU (strains CE113 and CE566) produced LPS lacking all O-
antigen-specific sugars, including QuiN (Table 2). Thus, it is
proposed thatWreU transfers QuiNAc-1-phosphate to the BpP
lipid carrier, thereby initiating O-antigen biosynthesis in R.
etli CE3.
Addition of sugars of the adaptor region by WreG, WreE,
WreS, and WreT. Because all mutant LPS samples had a large
proportion of LPS II, which containsmannose, sugar composition
data did not definitively identify the particular mutant unable to
add mannose to QuiNAc. Mutants defective in either one of two
glycosyltransferase genes,wreG orwreE, produced LPS containing
QuiN but lacking fucose (Table 2). Differences between the two
strains were revealed by Tricine SDS-PAGE (Fig. 3). The wreE
mutant produced an LPS of low abundance whose mobility was
barely resolved from that of LPS II, whereas any truncated LPS
produced by the wreGmutant was not resolved from LPS II. This
result suggests a shorter O antigen in the wreG mutant. Further-
more, the LPS profile of the wreE mutant on Tricine SDS-poly-
acrylamide gels was identical to those of fcl mutants, which as
expected also lacked fucose. All of these data support the assign-
ment of WreG as the glycosyltransferase responsible for the addi-
tion of mannose and WreE for the addition of the first fucose
(FucI).
Arguments stated in the introduction predict that the addi-
tions of the first two fucose residues (FucI and FucII) of the O
antigen require two different glycosyltransferases. The wreS mu-
tant produces a truncated LPSwhosemobility is lower than that of
the wreEmutant (Fig. 3), suggesting an O antigen having another
sugar residue after QuiNAc and mannose. Supporting this infer-
ence is the presence of fucose in composition analysis and the
ability to incorporate [3H]fucose into the truncated LPS of the
wreSmutant (Table 2 and Fig. 5), implicating WreS as the glyco-
syltransferase for the second fucose (FucII). Interestingly, the
genes proposed to be involved in the synthesis of GDP-fucose
(gmd and fcl) and the attachment of the first two fucose residues
(wreE and wreS) are located consecutively in the chromosomal
genetic cluster (Fig. 2A).
After two fucose residues have been added, the next glycosyl-
transferase would catalyze the addition of either MeGlcA or
3OMe6dTal. The wreTmutant produced the next fastest-moving
truncated LPS, which was found to contain QuiN and contain
twice as much fucose/QuiN as the wreS mutant but lack
3OMe6dTal (Fig. 3 and Table 2). Because all of the other mutants
not considered yet (wreH, wreM, and wreL mutants) do have
3OMe6dTal, it is proposed that this residue is added after the
second fucose and that WreT is the responsible enzyme. In order
FIG 6 R. etli CE3 O-antigen biosynthesis model. Current data indicate a synthesis model in which WreU attaches N-acetyl-quinovosamine-1-phosphate
(QuiNAc) to bactoprenol phosphate (BpP);WreG attachesmannose (Man) toQuiNAc;WreE attaches the first fucose (FucI);WreS attaches the fucose in the first
instance of the repeating unit (FucII); WreM attaches the fucoses of the second, third, fourth, and fifth repeating units (FucIII–VI); WreT attaches the
3-O-methyl-6-deoxytalose (3OMe6dTal) in the first instance of the repeating unit; WreL attaches 3OMe6dTal of the remaining repeating units; WreH attaches
the methyl glucuronate (MeGlcA) of each repeating unit; and WreB attaches the terminal residue. Abbreviation: P-P-Bp, bactoprenol pyrophosphate.
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to add 3OMe6dTal to the second fucose and not to the first one, it
seems likely that this enzyme has a stringent requirement that the
acceptor substrate has two fucose residues. As mentioned in the
introduction, this would be the only point in the synthesis of this
O antigen that an enzyme with this specificity could act. Hence, in
terms of the biosyntheticmechanism, this first 3OMe6dTal is pro-
posed to be the last residue of the adaptor region of the R. etliCE3
O antigen.
Additionof repeat-unit sugars byWreH,WreM, andWreL.
If the repeat unit is constructed by first adding 3OMe6dTal to the
second fucose residue, the next step must be the addition of
MeGlcA (Fig. 1) (or possibly GlcA before it is methylated). Using
mobility on SDS-polyacrylamide gels as an indication of relative
LPS length, the wreH mutant produced a truncated LPS larger
than that of the wreTmutant and smaller than that of the wreM
orwreLmutant (Fig. 3). WreH is therefore proposed as the glyco-
syltransferase that acts next after WreT. In support of this assign-
ment, sugar analysis showed the presence of QuiN, fucose, and
3OMe6dTal in the truncated LPS of this strain (Table 2). Also
consistentwith this assignment is the fact that, in thewreHmutant
LPS, GlcA content was at or barely above the background amount
observed from mutants that should have no GlcA, such as wreE,
wreS, and lpcAmutants. On the other hand, a considerably higher
content of GlcA above this background was detected in the wreT
mutant. A likely explanation is that while the WreH enzyme uses
the first 3OMe6dTal residue as part of its substrate recognition
and is therefore mainly blocked in the wreT mutant, WreH can
link MeGlcA to FucII at very low efficiency in the absence of
3OMe6dTal. Indeed, when purified wreT mutant LPS was over-
loaded on Tricine-SDS gels, a closely spaced ladder of bands that
stained less and less intensely as size increased could be observed
(Fig. 3 and data not shown). These bandswould be consistentwith
very small amounts of O antigen having variable numbers of
MeGlcA-Fuc- repeats. All of these considerations make it most
likely thatWreH is the glycosyltransferase that attachesMeGlcA as
shown in Fig. 6.
The first fucose (FucI) is attached by a 1,3-linkage to-D-man-
nose, the fucose of the first repeat unit (FucII) is linked by a 1,3-
linkage to the first -L-fucose, and the fucose of the second, third,
fourth, and fifth repeat units (FucIII-VI) is transferred to -D-
MeGlcA of the previous repeat unit by a 1,4-linkage (Fig. 1) (2,
13). Due to these different acceptor substrates and linkages, it is
expected that the addition of fucose in the latter repeating units
(FucIII-VI) requires a glycosyltransferase other thanWreEorWreS.
The wreM mutant produced one of the slowest-moving trun-
cated LPSs (Fig. 3), and it contained detectable amounts of all the
O-antigen sugars, including the terminal residue (Fig. 4C and Ta-
ble 2). In order for the terminal residue to be present, the residue
to which it is normally attached (MeGlcA) is also presumed to be
present. Apparently, in the absence of further elongation in this
mutant, the terminal residue can be attached, which is the func-
tion of WreB as previously reported (17). Interestingly, it appears
that the truncated O antigen, consisting of one repeat unit, does
not serve as an optimal substrate for WreB because the terminal
residue is not attached to all truncatedO antigens produced by the
wreM mutant, which explains the presence of the double-band
pattern seen onTricine gels and the relatively small amount of this
sugar in composition data (Fig. 3 and Table 2). The capability to
attach the terminal residue, combined with the observation that
the wreM defect results in a truncated LPS, implies that this
mutant likely cannot extend the O antigen beyond the sugars of
the first repeating unit. Thus, the fucose residues of the second,
third, fourth, and fifth repeating units (FucIII-VI) are added by the
WreM glycosyltransferase.
The truncated LPS from thewreLmutant was the slowestmov-
ing LPS on the SDS-polyacrylamide gel (Fig. 3), thereby implicat-
ing WreL as the next glycosyltransferase to act in O-antigen syn-
thesis. Considering the high similarity in protein sequence
betweenWreL andWreT (data not shown), it is a logical possibil-
ity that WreT adds 3OMe6dTal to the first repeat unit and WreL
adds this sugar to the subsequent repeat units. LPS sugar compo-
sitions are consistent with this conclusion: LPS produced by the
wreLmutant contained the same neutral and amino sugars as LPS
produced by the wreH mutant, the fucose/QuiN ratio from the
data in Table 2 is at least as high as that of the wreHmutant, and
the net GlcA/QuiN ratio is much higher in the wreLmutant than
in the wreH mutant. Consideration of these results, as well as the
deduced activities of the other predicted glycosyltransferases, leads to
the assignment of the role of WreL being the one indicated in Fig. 6.
This assignment completes the set of activities needed to link the
sugars together to obtain theR. etliCE3O-antigen structure that has
been determined by chemical analysis (13) (Fig. 1 and 6).
Significance of the low abundance of truncated LPSs. SDS-
PAGE is a common approach to identifying mutants defective in
genes required for the biosynthesis of the core and O-antigen re-
gions of LPS (52–55). Such analysis in R. etli reveals a set of mu-
tants producing stepwise truncations in the O antigen that, as
noted above, greatly aid in deducing functional assignments of
glycosyltransferases for each discrete step in O-antigen synthesis.
However, all of the glycosyltransferase mutants, with the excep-
tion of the wreB mutant, produce a truncated LPS in much less
abundance than LPS I of the wild type (Fig. 3). One possible ex-
planation is that the wild-type glycosyltransferase enzymes form
multisubunit O-antigen-synthesizing complexes, and the rate of
synthesis is reduced when the remaining enzymes cannot form
optimal complexes. Alternatively, the truncated O antigens may
not be ideal substrates for the ABC transporter or the O-antigen
ligase, such that the truncated O antigens are not readily translo-
cated across the inner membrane and/or attached to the core and
lipid A regions, respectively.
Summary. It is important to determine O-antigen structures
and understand their biosynthesis because of their central role in
mutualistic symbioses (e.g., Rhizobium [2, 16, 56, 57]) and patho-
genic symbioses (58, 59). This study has identified nine putative
glycosyltransferase genes within the known O-antigen genetic re-
gions, created mutants with defects in each gene, performed anal-
yses on the resulting mutant LPSs, and demonstrated each pre-
dicted glycosyltransferase to have a role in O-antigen synthesis.
The data support a model (Fig. 6) specifying the respective func-
tion of each predicted glycosyltransferase. It is a working hypoth-
esis that may not be correct in all respects, but all assignments are
based on evidence that is fully consistent with the assignments.
The value of the model is that it is comprehensive and makes
specific predictions of biosynthetic activities to be tested in future
experiments.
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